Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Lilly’s Cyramza Heading For Indian Debut?

This article was originally published in PharmAsia News

Executive Summary

Lilly appears to be on course to bringing its anticancer, Cyramza (ramucirumab), to India, after a key local expert panel recommended the product for marketing in two indications.



Related Companies